Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
The effect of intravenous ferric carboxymaltose on red cell distribution width: a subanalysis of the FAIR-HF study
Ist Teil von
European journal of heart failure, 2013-07, Vol.15 (7), p.756-762
Ort / Verlag
England: Blackwell Publishing Ltd
Erscheinungsjahr
2013
Quelle
Wiley Online Library - AutoHoldings Journals
Beschreibungen/Notizen
Aims
Red cell distribution width (RDW), a measure of variability in red blood cell size, is a novel prognostic marker in chronic heart failure (CHF). Iron deficiency contributes to elevated RDW. In the FAIR‐HF trial, i.v. ferric carboxymaltose (FCM) improved the 6 min walk test (6MWT) distance in iron‐deficient CHF patients. We studied the effect of FCM on RDW and the relationship between RDW and 6MWT distance.
Methods and results
In FAIR‐HF, iron‐deficient CHF patients were randomized to FCM or placebo in a 2:1 ratio. From the total cohort (n = 459), we included 415 patients in whom RDW values and 6MWT distance were available for baseline and at least one follow‐up visit (after 4, 12, and 24 weeks). Baseline RDW was higher in anaemic (haemoglobin <12 g/dL) compared with non‐anaemic patients [15.2% (14.0–16.8) vs. 14.2% (13.4–15.4), P < 0.0001, median (interquartile range)]. In multivariate analysis, RDW was significantly associated with transferrin saturation (P < 0.001) and C‐reactive protein levels (P = 0.002). Treatment with FCM led to a biphasic response; RDW increased within 4 weeks (+0.54% absolute change from baseline, P = 0.01) but fell to values below the placebo group after 24 weeks (–1.0 %, P = 0.03). The 6MWT distance and RDW were inversely related at baseline (r = –0.30, P < 0.0001). In all patients, the increase in 6MWT distance after 24 weeks was significantly correlated with a decrease in RDW (r= –0.25, P < 0.0001), even after adjustment for changes in haemoglobin.
Conclusions
Iron deficiency in CHF is associated with high RDW, even after adjustment for the presence of anaemia. Treatment with i.v. FCM in iron‐deficient CHF patients decreases RDW.